Millennium Management’s NewAmsterdam Pharma NAMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $495K | Buy |
27,345
+13,045
| +91% | +$236K | ﹤0.01% | 3375 |
|
|
2025
Q1 | $293K | Sell |
14,300
-479,930
| -97% | -$9.82M | ﹤0.01% | 3492 |
|
|
2024
Q4 | $12.7M | Buy |
494,230
+477,481
| +2,851% | +$12.3M | 0.01% | 1405 |
|
|
2024
Q3 | $278K | Sell |
16,749
-1,148,680
| -99% | -$19.1M | ﹤0.01% | 3592 |
|
|
2024
Q2 | $22.4M | Buy |
1,165,429
+217,902
| +23% | +$4.19M | 0.01% | 989 |
|
|
2024
Q1 | $22.4M | Sell |
947,527
-378,576
| -29% | -$8.95M | 0.01% | 999 |
|
|
2023
Q4 | $14.8M | Buy |
1,326,103
+281,319
| +27% | +$3.14M | 0.01% | 1221 |
|
|
2023
Q3 | $9.66M | Buy |
1,044,784
+671,232
| +180% | +$6.21M | ﹤0.01% | 1448 |
|
|
2023
Q2 | $4.44M | Buy |
373,552
+317,919
| +571% | +$3.78M | ﹤0.01% | 2019 |
|
|
2023
Q1 | $748K | Buy |
+55,633
| New | +$748K | ﹤0.01% | 3222 |
|